| Svenska Handelsbanken Q4 Earnings Fall | STOCKHOLM (dpa-AFX) - Svenska Handelsbanken AB (SHB-A.ST, SHB-B.ST, SVNLY), a banking products and services company, on Wednesday reported its income decreased in the fourth quarter compared... ► Artikel lesen |
| Svenska Handelsbanken AB: Highlights of Handelsbanken's Annual Report January - December 2025 | Q4 2025
(Q3 2025)
Operating profit was SEK 7,682m (7,768).
Return on equity was 13.0% (13.3).
Earnings per share were SEK 3.01 (3.00).
The C/I ratio was 40.7% (40.5).
The credit loss ratio... ► Artikel lesen |
| Svenska Handelsbanken 9-Month Earnings Slip | STOCKHOLM (dpa-AFX) - Svenska Handelsbanken AB (SVNLF), a Nordic lender, on Wednesday recorded a decline in earnings for the 9-month period.For the nine-month period to September, the company... ► Artikel lesen |
| EQT Foundation opens applications for breakthrough science grants to reduce dependence on critical minerals for the green transition | EQT Foundation opens applications for deeptech solutions grants, tackling critical mineral dependence in climate technologiesThe program will award between EUR 25,000 and EUR 100,000STOCKHOLM... ► Artikel lesen |
| EQT To Buy Coller Capital For Initial $3.2 Bln | LONDON (dpa-AFX) - EQT AB (EQT.ST, EQBBF), a Swedish investment company, said on Thursday that it has inked a deal to acquire Coller Capital, a British private equity company, for a base consideration... ► Artikel lesen |
| EQT AB (publ) Year-end Report 2025 | 2025 - A year of strong executionSTOCKHOLM, Jan. 22, 2026 /PRNewswire/ -- "2025 was a year of great progress and strong execution for EQT. We navigated a volatile market environment, achieved... ► Artikel lesen |
| XETR DELETION OF INSTRUMENTS FROM XETRA - 05.02.2026 | Das Instrument ZEG GB0009895292 ASTRAZENECA PLC DI DL-,25 EQUITY hat seinen letzten Handelstag am 05.02.2026: CONTINUOUS TRADING WITH AUCTIONS, PAG UKI0, SettlCurr EUR, CCP Y
The instrument ZEG GB0009895292... ► Artikel lesen |
| Erfolg für AstraZeneca | Der Pharmakonzern hat gestern gemeldet, dass sein Medikament Imfinzi in Kombination mit einer Chemotherapie für die Behandlung erwachsener Patienten mit Magen- sowie gastroösophagealen Übergangstumoren... ► Artikel lesen |
| New York Stock Exchange: NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer | NEW YORK, Feb. 3, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for... ► Artikel lesen |